Cabaletta Bio, Inc. announced the promotions of Gwendolyn Binder, Ph.D. to President of Science and Technology and Arun Das, M.D. to Chief Business Officer. In these new roles, Dr. Binder and Dr. Das will continue to report to Steven Nichtberger, M.D., Chief Executive Officer and Co-founder of Cabaletta. Dr. Binder was one of Cabaletta's first employees, joining in February 2019, and was most recently Executive Vice President of Science and Technology.

At Cabaletta, she established and currently leads the preclinical, translational, manufacturing and quality teams. Dr. Das joined Cabaletta in July 2019 and was most recently Executive Director of New Product Planning and Business Development before assuming his new role as Chief Business Officer.